Discover the Pasteur Institute's major discoveries for 2024

The Audiogene trial aims to correct the deficiency in a gene responsible for congenital deafness to restore hearing, using pioneering research conducted at the Institut Pasteur.

These antibodies, injected into the bloodstream, do not just act on the tumor; they also act on the lymph nodes, where many immune responses begin, raising hopes for more effective cancer treatments.

This approach could be used to improve predictions about the magnitude of dengue outbreaks several months in advance. The indicator, based on temperature fluctuations at the surface of the Indian Ocean, can also be used for any other world region.

The startup Eligo Bioscience – co-founded by Institut Pasteur laboratory head David Bikard, who is also the company’s scientific advisor – successfully edits the DNA of microbiome bacteria directly in the gut of a mouse model.

Romuald, the “Geneva patient”, is the only patient to experience HIV remission after receiving a bone marrow transplant without the CCR5-delta 32 mutation, known to make CD4 cells resistant to the virus.

Scientists develop an AI model capable of making a tailored selection of phages by analyzing the genome of targeted bacteria.